National HealthCare Corporation (NHC) posted Q2 2025 net operating revenues of $374.9 million, up 24.7% year-over-year, driven by higher same-facility revenues and the White Oak acquisition. GAAP net income was $23.7 million, with diluted EPS of $1.52. Operating income reached $34.1 million.

National HealthCare Corporation reported a decrease in GAAP net income but an increase in adjusted net income for the quarter ended December 31, 2024. The GAAP net income attributable to NHC was $6.081 million, while the adjusted net income was $25.954 million. Diluted earnings per share were $0.39 GAAP and $1.66 non-GAAP.

National HealthCare Corporation reported a strong third quarter in 2024, with a 17.9% increase in net operating revenues and grant income, primarily driven by the acquisition of White Oak Manor. GAAP net income attributable to NHC significantly increased, along with adjusted net income and diluted earnings per share.

National HealthCare Corporation reported a 6.4% increase in net operating revenues and grant income for the quarter ended June 30, 2024, totaling $300,658,000. GAAP net income attributable to NHC was $26,844,000, compared to $16,281,000 for the same period in 2023. The GAAP diluted earnings per share were $1.73 for the quarter ended June 30, 2024.

National HealthCare Corporation announced a strong first quarter with a 10.2% increase in net operating revenues, reaching $297,176,000. GAAP net income attributable to NHC saw a substantial rise to $26,213,000 compared to the same period last year. Adjusted net income also increased by 24.7% to $15,048,000.

National HealthCare Corporation (NHC) reported a strong financial performance for the quarter ended December 31, 2023, with a notable increase in GAAP net income attributable to NHC, rising to $28,406,000 compared to $6,353,000 for the same period in 2022. Adjusted net income also saw a substantial increase, reaching $15,955,000 compared to $11,046,000 in the prior year. Diluted earnings per share increased to $1.83, compared to $0.41 for the same quarter last year.

National HealthCare Corporation reported a 6.5% increase in net operating revenues and grant income, reaching $288,485,000 for the quarter ended September 30, 2023. GAAP net income attributable to NHC was $10,388,000, compared to a net loss of $2,429,000 for the same period in 2022. Adjusted net income was $13,250,000, compared to $7,783,000 in the previous year.

National HealthCare Corporation (NHC) announced a 4.1% increase in net operating revenues and grant income for Q2 2023, totaling $282,582,000 compared to $271,359,000 in Q2 2022. GAAP net income attributable to NHC was $16,281,000, a significant increase from $3,203,000 in the same period last year. The GAAP diluted earnings per share rose to $1.06, compared to $0.21 for the quarter ended June 30, 2022.

National HealthCare Corporation reported a decrease in net operating revenues and net income for the quarter ended March 31, 2023, compared to the same period in 2022. The decrease was primarily due to a reduction in government stimulus income. Excluding the government stimulus income and the exited facilities, same-facility net operating revenues increased.

National HealthCare Corporation reported a decrease in net income for the quarter ended December 31, 2022, compared to the same period in 2021, primarily due to a reduction in government stimulus income. GAAP diluted earnings per share were $0.41, and adjusted diluted earnings per share were $0.72.

National HealthCare Corporation reported net operating revenues of $270.84 million and a GAAP net loss attributable to NHC of $2.43 million for the quarter ended September 30, 2022. The decrease in net operating revenues was primarily driven by a reduction in government stimulus income and exiting seven skilled nursing facilities. Adjusted net income for the quarter was $7.78 million, compared to $14.88 million for the same period in 2021.

National HealthCare Corporation reported a 3.1% increase in net operating revenues and government stimulus income, totaling $271,359,000 for the quarter ended June 30, 2022. However, GAAP net income attributable to NHC decreased to $3,203,000 compared to $104,883,000 for the same period in 2021. The decrease in non-GAAP earnings was primarily due to reduced government stimulus income and inflationary wage pressures.

National HealthCare Corporation reported an 11.2% increase in net operating revenues and grant income for Q1 2022, reaching $278,983,000. However, net income attributable to NHC decreased to $15,318,000, and adjusted net income also declined due to reduced government stimulus and higher labor costs.

National HealthCare Corporation reported an increase in adjusted net income for the quarter ended December 31, 2021, compared to the same period in 2020. The GAAP diluted earnings per share were $1.02, and adjusted diluted earnings per share were $1.02.

National HealthCare Corporation reported a GAAP net loss attributable to NHC of $3,348,000 for the quarter ended September 30, 2021, compared to net income of $12,849,000 for the same period in 2020. However, adjusted net income, excluding unrealized losses in marketable equity securities, increased by 10.5% to $14,884,000. The increase in net operating revenues was primarily driven by the acquisition of Caris Healthcare and an increase in census in skilled nursing facilities.

National HealthCare Corporation reported a rise in net operating revenues and CARES Act income to $263.158 million. GAAP net income attributable to NHC increased significantly to $104.883 million, primarily due to the acquisition of Caris HealthCare, L.P. Adjusted net income, excluding the acquisition gain and other non-GAAP adjustments, was $15.077 million.

National HealthCare Corporation reported net operating revenues and CARES Act income of $250,973,000 for Q1 2021, a decrease of 2.0% compared to Q1 2020. GAAP net income attributable to NHC was $21,267,000, compared to a net loss of $26,852,000 in the same period of 2020. GAAP diluted earnings per share was $1.38, compared to a diluted loss per share of $1.76 in the same period of 2020.

National HealthCare Corporation reported a 2.3% increase in net operating revenues and CARES Act income for the quarter ended December 31, 2020. GAAP net income attributable to NHC was $27.55 million for the same period.

National HealthCare Corporation (NHC) reported a 1.4% increase in net operating revenues and CARES Act funding for Q3 2020, totaling $250,626,000. GAAP net income attributable to NHC was $12,849,000, with a reported GAAP diluted earnings per share of $0.84.

National HealthCare Corporation reported a 5.9% increase in net operating revenues and grant income for the quarter ended June 30, 2020, totaling $261,642,000. GAAP net income attributable to NHC was $28,324,000, compared to $13,711,000 for the second quarter of 2019. The reported GAAP diluted earnings per share was $1.84, and the adjusted diluted earnings per share was $0.92.

National HealthCare Corporation reported a net operating revenue increase of 3.2% for the quarter ended March 31, 2020. However, the company experienced a GAAP net loss attributable to NHC, contrasting with a net income in the same quarter of the previous year. Adjusted net income, excluding unrealized gains and losses, showed a slight increase compared to the first quarter of 2019.

National HealthCare Corporation reported a 2.0% increase in net operating revenues for the quarter ended December 31, 2019, totaling $253.88 million. However, GAAP net income attributable to NHC decreased to $13.77 million compared to $18.152 million in Q4 2018.